Skip to content

The most extended virus collection with a One Health vision

Virus collection

For human and animal, antiviral screening

We can manage the construction of any kind of autofluorescent viruses or viral vectors for imaging application. We work on different kind of starting materials, from plasmid to large oncolytic vectors. Our technology has been applied to investigate the dynamics of a broad variety of DNA. Our virus collection is constantly expending.

As the ANCHOR system is not suitable to tag RNA viruses, we use classical virology readouts such as high throughput quantification of cytopathic effect, TCID50 or qPCR. Other readouts such as high throughput immunofluorescence are also available for some viruses.

DNA viruses and ANCHOR™ tagged viruses

Any viruses having a dsDNA phase can be tagged with ANCHOR™. Here you will find a list of viruses available for immediate use. We annually expand this collection with new viruses to quickly respond to human or veterinary threats.

Your virus of interest is not in this list? Do not hesitate to contact us, we will find a solution!

Note: Viruses having biodefense applications are underlined. Italic implies availability of in vivo efficacy testing

Human market

Herpes virus
Poxvirus
  • Vaccinia virus ANCHOR (Ankara) ☜
  • Vaccinia Western Reserve ANCHOR (in construction)
  • Monkeypox ANCHOR (in construction, collaboration with Army biological research institute)
Retrovirus
  • Lentivirus HIV1 derived ANCHOR (several including IN deficient, in collaboration with GEG Tech)
  • HIV1 ANCH (in collaboration with  Pasteur Institute)
  • HPV16 ANCH (in collaboration with Munster university)
Adenovirus and AAV
  • hAdv5 ANCHOR ☜ (published Komatsu et al. J.Virol 2018)
  • hAdv40
  • scAAV2 ANCHOR

Animal market

Poxvirus
  • MYXV Vaccinal strain ANCHOR
  • MYXV pathogenous strain ANCHOR
  • AFSV ANCHOR (in collaboration with Madrid University)
  • Cowpox ANCHOR (Brighton)
Herpes virus
  • Equine Herpes Virus 1 ANCHOR
  • FaHV-1

RNA viruses

We have a collection of RNA viruses that we use in routine for antiviral discovery and measurment of disinfection procedures

Note: Viruses having biodefense applications are underlined. Italic implies availability of in vivo efficacy testing

Human market

RNA viruses

Animal market

RNA viruses
  • Feline Calicivirus
  • Canine Parvovirus
  • Avian influenza (including highly pathogenous H5N8)